Just In
- 1 hr ago Aditi Rao Hydari's 8 Tips for Glowing Skin: A Celebrity Skincare Routine Unveiled, Bonus Tips Included!
- 2 hrs ago April 2024 Health Horoscope: Know How This Month Will Affect Zodiac Signs In Terms Of Wellness
- 3 hrs ago Good Friday 2024: Wishes, Messages, Greetings, Texts, Images, Quotes, WhatsApp, And FB Status
- 10 hrs ago Aditi Rao Hydari Marries Siddharth, Exploring Heeramandi Star's Ethnic Style Statements, Bookmark Now!
Don't Miss
- Sports Rajasthan Royals Rising Star Riyan Parag's Redemption Story Takes Center Stage in IPL 2024
- Movies Krishna Mohini Promo: Fahmaan Khan- Debattama Saha's New Show Looks Promising, To REPLACE THIS Drama?
- Finance 1,190% Dividend Payout Soon: UBS Optimistic On Electrical Stock ABB, Recommends Buy For Rs 7,550 TP
- News Jailed Gangster-Turned-Politician Mukhtar Ansari Dies Of Heart Attack
- Automobiles Xiaomi SU7 Electric Car Launched – May End Apple Inc.
- Technology HONOR Pad 9 With Bluetooth Keyboard Up For Grabs At Rs 22,499 in India
- Education RSMSSB Junior Instructor Recruitment 2024; Apply online for 2500 Posts, Check out for more details
- Travel Explore Tamil Nadu's Diverse Wedding Venues
Covid-19 Vaccines For Kids: DCGI Grants Emergency Use Nod To 3 Vaccines For Different Age Group Of Children
On Tuesday (26 April), the Drugs Controller General of India (DCGI) approved three Covid-19 vaccines for restricted emergency use authorisation (EUA) in children of various ages.
Bharat Biotech's Covaxin received a restricted EUA from the DCGI for children aged 6 to12. Similarly, Biological E's Covid-19 vaccine Corbevax has been approved for children aged 5 to 12 years.
Further, along with Corbevax and Covaxin, the DCGI has also approved Zydus Cadila's Covid-19 vaccine ZyCoV-D for children over the age of 12 years for a two-dose regimen.
This development happened after the Subject Expert Committee's (SEC) discussion of suggestions for the emergency use of Covaxin in children aged 6 to 12 years due to an increase in covid-19 cases in schools.
Covaxin has proven to be effective for adults and is also presently being given to youngsters aged 15 to 18. To give EUA to Covaxin for children aged 6-12 years, experts had requested more information from the corporation, which was delivered on Friday. The SEC was satisfied with the provided data and thus, nods for its EUA among children aged 6-12 years.
As the focus was mainly on the increasing number of cases among children, the SEC has also recommended emergency use of Biological E's Covid-19 vaccine Corbevax and ZyCoV-D.
- pregnancy parentingMysterious Pneumonia Outbreak In China: What Are The Long-Term Effects Of Pneumonia In Children?
- healthCan You Get Back COVID-Related Loss Of Sense Of Smell And Taste (Parosmia)? Looks Like You Can!
- healthDid Covid-10 Vaccination Increase Risk Of Sudden Deaths In Young Adults? ICMR Finds This..
- wellnessDelhi Air Pollution, Air Quality Very Poor: Do Covid Masks Help Reduce Pollution Side Effects?
- healthNobel Prize 2023: Scientists Behind The COVID-19 mRNA Vaccines Wins
- healthWhat Is Disease X? 20 Times More Deadlier Than Covid 19; Can Cause 50 Million Deaths, Does It Have Vaccine?
- healthCOVID-19 Vaccines and Heart Attacks: New Studies Show Different Results; What Are They?
- healthDo You Pick Your Nose? Stop! It Can Increase COVID Risk
- healthEris Variant: WHO Alarms New Covid Wave; Should India Be Concerned About This Pandemic
- healthVitamin D Deficiency Linked With Increased Risk Of Long COVID
- healthCOVID Surge In India: Do You Need A COVID-19 Booster Shot?
- healthCOVID-19: IMA Cites 3 Reasons Behind Recent Surge In Covid-19 Cases: What Are They?